Decision letter for "Anti‐EpCAM RNA aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model"

2020 ◽  
Keyword(s):  
Targeted Therapy ◽  
Colon Carcinoma ◽  
Liposomal Doxorubicin ◽  
Tumor Model ◽  
Carcinoma Tumor

Author response for "Anti‐EpCAM RNA aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model"

2020 ◽  
Author(s):  
Mohammad Mashreghi ◽  
Parvin Zamani ◽  
Maryam Karimi ◽  
Amin Mehrabian ◽  
Mahdieh Arabsalmani ◽  
...  
Keyword(s):  
Targeted Therapy ◽  
Colon Carcinoma ◽  
Liposomal Doxorubicin ◽  
Tumor Model ◽  
Author Response ◽  
Carcinoma Tumor

Anti‐EpCAM RNA aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model

2020 ◽  
Author(s):  
Mohammad Mashreghi ◽  
Parvin Zamani ◽  
Maryam Karimi ◽  
Amin Mehrabian ◽  
Mahdieh Arabsalmani ◽  
...  
Keyword(s):  
Targeted Therapy ◽  
Colon Carcinoma ◽  
Liposomal Doxorubicin ◽  
Tumor Model ◽  
Rna Aptamer ◽  
Carcinoma Tumor

scholarly journals Aryl hydrocarbon receptor acts as a tumor suppressor in a syngeneic MC38 colon carcinoma tumor model

Hypoxia ◽  
2019 ◽  
Vol Volume 7 ◽  
pp. 1-16
Author(s):  
Poonam Yakkundi ◽  
Eleanor Gonsalves ◽  
Maria Galou-Lameyer ◽  
Mark Selby ◽  
William Chan
Keyword(s):  
Tumor Suppressor ◽  
Aryl Hydrocarbon Receptor ◽  
Colon Carcinoma ◽  
Tumor Model ◽  
Aryl Hydrocarbon ◽  
Carcinoma Tumor
Sign in / Sign up

Export Citation Format

Share Document